Position in AZN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$1,297,190
New position
Shares Held
6,841
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#604
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cyndeo Wealth Partners, LLC holds $116,144,822 across 9 Drug Manufacturers - General names. AZN ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
137,211 | $34,527,776 | |
| 2 | LLY |
ELI LILLY & Co
|
17,927 | $21,502,183 | |
| 3 | JNJ |
Johnson & Johnson
|
78,287 | $19,882,549 | |
| 4 | MRK |
Merck & Co., Inc.
|
108,426 | $13,932,741 | |
| 5 | PFE |
Pfizer Inc
|
536,714 | $12,924,073 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
186,460 | $10,743,825 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
6,841 | $1,297,190 | |
| 8 | NVS |
Novartis AG
|
4,490 | $703,672 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,297,190 | 6,841 | Shares | Sole | 2026-07-21 | |
| No filing history on record for this holder in this stock. | ||||||